Concepedia
Statistics
Publications
5
Citations
122
H-Index
Active since
1998
Affiliations
University of Colorado Denver(Current)
Huntsman Cancer Institute
Miragen Therapeutics (United States)
City of Hope
University of Utah
Mark Sanseverino is an author at University of Colorado Denver specializing in life sciences, oncology, and biochemistry.
Publications per year
1998–2023
Preliminary Results of a Phase 1 Trial Evaluating MRG-106, a Synthetic microRNA Antagonist (LNA antimiR) of microRNA-155, in Patients with CTCL
Christiane Querfeld, Theresa Pacheco, Francine M. Foss et al. · Blood · 2016 · 53 citations
Life Sciences, Molecular Biology, Oncology +13
Phase 1 trial evaluating MRG-106, a synthetic inhibitor of microRNA-155, in patients with cutaneous t-cell lymphoma (CTCL).
Francine M. Foss, Christiane Querfeld, Pierluigi Porcu et al. · Journal of Clinical Oncology · 2017 · 26 citations
Medicine, Oncology, Pharmacotherapy +14
OSWG Recommended Approaches to the Nonclinical Pharmacokinetic (ADME) Characterization of Therapeutic Oligonucleotides
Madeleine Antonsson, Sándor Bátkai, Sieto Bosgra et al. · Nucleic Acid Therapeutics · 2023 · 15 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +8
An efficient synthesis of the ribozyme–folate conjugate
Jasenka Matulić‐Adamić, Mark Sanseverino, Leonid Beigelman · Tetrahedron Letters · 2002 · 14 citations
Life Sciences, Biochemistry, Molecular Biology +10
Phosphatidylinositol-specific phospholipase C isoform expression in pregnant and nonpregnant rat myometrial tissue
Eric J. Bieber, Thomas Stratman, Mark Sanseverino et al. · American Journal of Obstetrics and Gynecology · 1998 · 14 citations
Life Sciences, Biochemistry, Cell Biology +13
1–5 of 5